Ev » Tüm » Hisse Tahmini » Uro Gen Pharma Ltd. Ordinary Shares Tahmin etmek

Uro Gen Pharma Ltd. Ordinary Shares Tahmin etmek: Yarın, Hafta, Ay, 5 Yıl

Güncellendi: April 22 · 2026 at 07:03 UTC

From

▲ +0.44%Market Cap $1.22B · Technical analysis Bullish · Focus area Price + volatility

Tahmin Özeti

Zaman aralığı	Tahmini Fiyat	Geçmiş	Tarihsel	İç yüzü
Yarın	$24.85 ▼ -0.71%	Dün	$25.10 ▲ +0.30%	Tomorrow's UroGen Pharma Ltd. Ordinary Shares (URGN) setup is anchored to $25.03 and targets $24.85 (-0.71%). The near-term read is downside; watch $25.78 / $24.28 because daily realized volatility is about 3.65%.
Tomorrow's UroGen Pharma Ltd. Ordinary Shares (URGN) setup is anchored to $25.03 and targets $24.85 (-0.71%). The near-term read is downside; watch $25.78 / $24.28 because daily realized volatility is about 3.65%.
Hafta	$24.48 ▼ -2.20%	Geçen hafta	$25.26 ▲ +0.92%	The 7-day UroGen Pharma Ltd. Ordinary Shares model moves from $25.26 to $24.48 (-2.20%). It gives downside momentum context for this stock, so breaks around $25.78 / $24.28 matter more than a single tick.
The 7-day UroGen Pharma Ltd. Ordinary Shares model moves from $25.26 to $24.48 (-2.20%). It gives downside momentum context for this stock, so breaks around $25.78 / $24.28 matter more than a single tick.
Ay	$23.86 ▼ -4.69%	Geçen ay	$25.52 ▲ +1.97%	The 1-month UroGen Pharma Ltd. Ordinary Shares target is $23.86 (-4.69%), compared with the live reference near $25.03. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month UroGen Pharma Ltd. Ordinary Shares target is $23.86 (-4.69%), compared with the live reference near $25.03. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Yıl	$22.92 ▼ -8.41%	Geçen sene	$25.91 ▲ +3.53%	The 1-year UroGen Pharma Ltd. Ordinary Shares scenario points to $22.92 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year UroGen Pharma Ltd. Ordinary Shares scenario points to $22.92 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Yıl	$20.74 ▼ -17.14%	5 Yıl Önce	$26.83 ▲ +7.20%	The 5-year UroGen Pharma Ltd. Ordinary Shares view is $20.74 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year UroGen Pharma Ltd. Ordinary Shares view is $20.74 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Yarın$24.85▼ -0.71%

Dün$25.10▲ +0.30%

Tomorrow's UroGen Pharma Ltd. Ordinary Shares (URGN) setup is anchored to $25.03 and targets $24.85 (-0.71%). The near-term read is downside; watch $25.78 / $24.28 because daily realized volatility is about 3.65%.

Hafta$24.48▼ -2.20%

Geçen hafta$25.26▲ +0.92%

The 7-day UroGen Pharma Ltd. Ordinary Shares model moves from $25.26 to $24.48 (-2.20%). It gives downside momentum context for this stock, so breaks around $25.78 / $24.28 matter more than a single tick.

Ay$23.86▼ -4.69%

Geçen ay$25.52▲ +1.97%

The 1-month UroGen Pharma Ltd. Ordinary Shares target is $23.86 (-4.69%), compared with the live reference near $25.03. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Yıl$22.92▼ -8.41%

Geçen sene$25.91▲ +3.53%

The 1-year UroGen Pharma Ltd. Ordinary Shares scenario points to $22.92 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Yıl$20.74▼ -17.14%

5 Yıl Önce$26.83▲ +7.20%

The 5-year UroGen Pharma Ltd. Ordinary Shares view is $20.74 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Fiyat Tablosu

TarihselTahmin etmekYükselişdüşüş eğilimi

Teknik Analiz

Neutral

Yükseliş

Doğal

düşüş eğilimi

Temel Göstergeler

Gösterge	Değer	Sinyal
Price	$25.03	Mid
Daily Change	+0.44%	Above
Volatility Cap	20.0%	Mid
Confidence	58%	Below
Data Source	nasdaq-screener	Mid

Geçmiş Veriler

Current$25.03

Daily Change+0.44%

Market Cap$1.22B

Sourcenasdaq-screener

Current	$25.03	Daily Change	+0.44%
Market Cap	$1.22B	Source	nasdaq-screener

Destek ve Direnç Seviyeleri

$24.28Support 1

$25.03Akım

$25.78Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Fiyat Aşamaları

Anahtar seviyeler ve tarihsel bağlam

Current$25.03Live reference price

Used as the anchor for generated forecast calculations.

Next Month$23.86Model projection-4.69%

Directional scenario based on capped drift.

Tahmin Doğruluğu

Modelimizin performansı nasıl?

58%

Yönlü

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Algoritmamız, en son fiyat hareketi, oynaklık rejimi ve gösterge sinyalleri kullanılarak haftalık olarak yeniden kalibre edilir. Doğruluk zaman dilimine göre değişir; kısa vadeli momentum, uzun vadeli tahminlerden daha güvenilirdir.

Short term

58%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Yatırım Senaryoları

Bugün $1,000'yu URGN'ya yatırırsanız

Bullish Scenario

$26.28

+5.00% from current

Hedef Fiyat$26.28

SenaryoUpside momentum

Olasılık50%

Base Scenario

$23.86

-4.69%

Hedef Fiyat$23.86

SenaryoCapped drift

Olasılık58%

Bearish Scenario

$23.78

-5.00% from current

Hedef Fiyat$23.78

SenaryoVolatility drawdown

Olasılık42%

Temel: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Tahmin Faktörleri

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.71%

7D drift-2.20%

30D drift-4.69%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.69%

1Y outlook-8.41%

5Y outlook-17.14%

Sıkça Sorulan Sorular

Q What is the UroGen Pharma Ltd. Ordinary Shares (URGN) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), UroGen Pharma Ltd. Ordinary Shares is projected near $24.85 versus the current reference around $25.03. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for URGN?

The weekly UroGen Pharma Ltd. Ordinary Shares model points to $24.48, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the UroGen Pharma Ltd. Ordinary Shares 1-month and 1-year targets?

The UroGen Pharma Ltd. Ordinary Shares 1-month target is $23.86 (-4.69%), while the 1-year target is $22.92 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the UroGen Pharma Ltd. Ordinary Shares 5-year scenario differ from short-term rows?

The UroGen Pharma Ltd. Ordinary Shares long-horizon scenario sits near $20.74 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are URGN support and resistance zones right now?

For UroGen Pharma Ltd. Ordinary Shares, nearest resistance is around $24.28, while nearest support is around $25.78. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the UroGen Pharma Ltd. Ordinary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.